{
    "2019-07-01": [
        [
            {
                "time": "2019-07-02",
                "original_text": "一批被踢出市场的药品要回来了？百亿销量“神话”难续",
                "features": {
                    "keywords": [
                        "药品回归",
                        "百亿销量",
                        "市场变化"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-07-02",
                "original_text": "抗抑郁药文拉法辛市场规模达十亿 复星有望首家过评",
                "features": {
                    "keywords": [
                        "抗抑郁药",
                        "文拉法辛",
                        "复星医药",
                        "市场规模"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-07-02",
                "original_text": "力思特拟7.5亿卖身复星医药谋曲线上市 单一产品贡献近九成销售收入存风险",
                "features": {
                    "keywords": [
                        "力思特",
                        "复星医药",
                        "曲线上市",
                        "单一产品风险"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2019-07-02",
                "original_text": "【医药】江琦、赵磊：行业点评：看好审评审批改革持续推动下的中国创新药产业发展-20190702",
                "features": {
                    "keywords": [
                        "审评审批改革",
                        "创新药产业",
                        "政策利好"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}